62638 Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 

information request collection title for 

reference. 

Information Collection Request Title: 

Be The Match® Patient Services Survey 

OMB No. 0915–xxxx—NEW 

Abstract: National Marrow Donor 

Program®/Be The Match® is dedicated 

to helping patients and families get the 

support and information they need to 

learn about their disease and treatment 

options, prepare for transplant, and 

thrive after transplant. The information 

and resources provided are intended to 

help navigate the bone marrow or cord 

blood transplant (transplant) process. 

Participant feedback is essential to 

understand the needs for transplant 

support services and educational 

information across a diverse population. 

This information will be used to 

determine helpfulness of existing 

services and resources. Feedback is also 

used to identify areas for improvement 

and to develop future programs. 

Need and Proposed Use of the 

Information: Barriers restricting access 

to bone marrow or cord blood transplant 

(transplant) related care and educational 

information are multi-factorial. 

Feedback from participants is essential 

to better understand the changing needs 

for services and information as well as 

to demonstrate the effectiveness of 

existing services. The primary use for 

information gathered through the survey 

is to determine helpfulness of 

participants’ initial contact with Be The 

Match® Patient Services Coordinators 

(PSC) and to identify areas for 

improvement in the delivery of services. 

The survey will include these items to 

measure: (1) Reason for contacting Be 

The Match®; (2) if the PSC was able to 

answer questions and easy to 

understand; (3) if the contact helped the 

participant to feel better prepared to 

discuss transplant with their care team; 

(4) increase in awareness of available 

resources; (5) timeliness of response; 

and (6) overall satisfaction. Stakeholders 

utilize this evaluation data to make 

program and resource allocation 

decisions. 

Likely Respondents: Respondents will 

include patients, caregivers, and family 

members contacting Be The Match®

Patient Services Coordinators. 

Respondents will include all patients, 

caregivers, and family members who 

have contact with Be The Match®

Patient Services Coordinators via phone 

or email for transplant navigation 

services and support (advocacy). The 

decision to survey all participants was 

made based on historic evidence of 

patients’ unavailability due to frequent 

transitions in health status as well as 

between home and the hospital for 

initial treatment and care for 

complications. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Be The Match® Patient Services Survey ............................ 420 1 420 0.25 105 

Total .............................................................................. 420 1 420 0.25 105 

The total respondent burden for the 

satisfaction survey is estimated to be 

105 hours. We expect a total of 420 

respondents (33% response rate) to 

complete the Be The Match® Patient 

Services Survey. 

Dated: October 10, 2014. 

Jackie Painter, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2014–24872 Filed 10–17–14; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Privacy Act of 1974; Deletion of an 

Existing System of Records 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice to delete an obsolete 

system of records. 

SUMMARY: In accordance with the 

requirements of the Privacy Act of 1974, 

HRSA is deleting an obsolete system of 

records titled the Information Center 

(IC) Integrated Clearinghouse System 

(ICS), HRSA 09–15–0067, established in 

2007 at 72 FR 34018 and 72 FR 44846. 

DATES: Effective Date: The deletion will 

be effective upon publication of this 

Notice. 

ADDRESSES: The public should address 

any comments to: David Bowman, 

Office of Communications, HRSA, RM 

16–70, 5600 Fishers Lane, Rockville, 

Maryland, and 301–443–3376. 

Comments received will be available for 

review at this location, by appointment, 

during regular business hours, Monday 

through Friday from 9 a.m.–3 p.m., 

Eastern Time Zone. 

SUPPLEMENTARY INFORMATION: HRSA’s 

Office of Communications operated the 

IC/ICS system as part of the larger HRSA 

Information Center, which provided 

information on HRSA’s many programs 

in response to public inquiries. The 

purpose of the IC/ICS system of records 

was to provide for the safekeeping of 

customers’ personally identifiable 

information captured and retained by 

the system for the period of 1 year for 

quality assurance purposes associated 

with voluntary requests for publications 

and other information. On September 2, 

2014, the HRSA IC closed and ceased 

operations and all personallyidentifiable records were deleted from 

the system; therefore this system of 

records is no longer maintained. 

Accordingly, the Information Center 

(IC) Integrated Clearinghouse System 

(ICS), HRSA 09–15–0067, is hereby 

deleted as obsolete. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 202 / Monday, October 20, 2014 / Notices 62639 

Dated: October 14, 2014. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2014–24868 Filed 10–17–14; 8:45 am] 

BILLING CODE 4160–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 552b(c) 

(4) and 552b(c) (6), Title 5 U.S.C., as 

amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Omnibus 

R03/R21 SEP–7. 

Date: November 12, 2014. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute Shady 

Grove, 9609 Medical Center Drive, Room 

TE406, Rockville, MD 20850. 

Contact Person: Timothy C. Meeker, MD, 

Ph.D., Scientific Review Officer, Resource 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 9609 Medical Center Drive, Room 

7W606, Rockville, MD 20850, 240–276–6464, 

meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Innovative 

Molecular Analysis Technologies. 

Date: February 24–25, 2015. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Donald L. Coppock, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division Of Extramural Activities, National 

Cancer Institute, 9609 Medical Center Drive, 

Room 7W260, Bethesda, MD 20892, 240– 

276–6382, donald.coppock@nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 14, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24788 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; NEI Cooperative 

Agreement and Clinical Applications. 

Date: November 5, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Garden Inn, 7301 Waverly 

Street, Bethesda, MD 20814. 

Contact Person: Brian Hoshaw, Ph.D., 

Scientific Review Officer, National Eye 

Institute, National Institutes of Health, 

Division of Extramural Research, 5635 

Fishers Lane, Suite 1300, Rockville, MD 

20892, 301–451–2020, hoshawb@

mail.nih.gov. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; NEI K Training and 

R13 Conference Grant Applications. 

Date: November 6–7, 2014. 

Time: 8:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Suite 

1300, 5635 Fishers Lane, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Jeanette M. Hosseini, 

Ph.D., Scientific Review Officer, 5635 Fishers 

Lane, Suite 1300, Bethesda, MD 20892, 301– 

451–2020, jeanetteh@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: October 14, 2014. 

Melanie J. Gray-Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24787 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; CNS Effects of HIV. 

Date: November 20, 2014. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Telephone 

Conference Call). 

Contact Person: JoAnn McConnell, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS/Neuroscience Center, 

6001 Executive Boulevard, Suite 3208, MSC 

9529, Bethesda, MD 20892–9529, 301–496– 

5324, mcconnej@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: October 14, 2014. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24784 Filed 10–17–14; 8:45 am] 

BILLING CODE 4140–01–P 


tkelley on DSK3SPTVN1PROD with NOTICES